Natera and Angiex partner to assess nuclear-delivered ADC with Signatera
Natera and Angiex will assess response to an investigational nuclear-delivered antibody-drug conjugate using Signatera.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.